P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
6.07
+0.04 (0.66%)
Jun 25, 2025, 4:00 PM - Market closed
P3 Health Partners Stock Forecast
Stock Price Forecast
The 2 analysts that cover P3 Health Partners stock have a consensus rating of "Buy" and an average price target of $16.25, which forecasts a 167.71% increase in the stock price over the next year. The lowest target is $12.5 and the highest is $20.
Price Target: $16.25 (+167.71%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 21, 2025.
Analyst Ratings
The average analyst rating for P3 Health Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $50 → $20 | Strong Buy | Maintains | $50 → $20 | +229.49% | Apr 21, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $45 → $13 | Hold | Maintains | $45 → $13 | +105.93% | Nov 20, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $450 → $225 | Strong Buy | Maintains | $450 → $225 | +3,606.75% | Mar 14, 2024 |
| BTIG | BTIG | Strong Buy Initiates $250 | Strong Buy | Initiates | $250 | +4,018.62% | Sep 1, 2023 |
Financial Forecast
Revenue This Year
1.45B
from 1.50B
Decreased by -3.56%
Revenue Next Year
1.53B
from 1.45B
Increased by 6.01%
EPS This Year
-23.82
from -54.06
EPS Next Year
-17.55
from -23.82
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.5B | 1.7B | 1.7B |
| Avg | 1.4B | 1.5B | 1.6B |
| Low | 1.4B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.2% | 17.1% | 7.6% |
| Avg | -3.6% | 6.0% | 4.5% |
| Low | -8.6% | -5.2% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.75 | -9.57 | -9.98 |
| Avg | -23.82 | -17.55 | -9.69 |
| Low | -39.69 | -26.46 | -9.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.